Ajovy for Migraine Prevention: Monthly or Quarterly Injections

Ajovy (fremanezumab-vfrm) is an injectable prescription medicine for migraine prevention. Adults can use a monthly or quarterly schedule prescribed by their clinician. It is not an injection to take whenever a migraine starts. Understanding the schedule, safety warnings, and refill process helps you decide whether Ajovy fits your treatment plan. [1]

How does Ajovy prevent migraine?

Ajovy is a monoclonal antibody that binds calcitonin gene-related peptide, or CGRP, and keeps that signal from attaching to its receptor. CGRP is involved in migraine. This is a targeted preventive approach; it does not mean migraine has only one cause or that every attack will disappear. [1]

Current headache guidance includes CGRP therapies among first-line prevention options. A choice should account for evidence, side effects, daily-life impact, and access. [4] Think about both frequency and disruption: a few prolonged attacks that repeatedly interrupt work deserve discussion, even if you know someone who has more headache days.

A preventive and an acute medicine serve different purposes. You may still need a clinician-approved plan for breakthrough attacks while using Ajovy. Our article Medicines for attacks versus prevention explains how those roles fit together. Repeatedly needing more attack medicine is also useful information for a follow-up.

Monthly or quarterly: what is the difference?

The following table describes the adult U.S. dosing options. It provides label education, not a personal dosing recommendation. Both schedules involve injections under the skin. Use the regimen prescribed for you and discuss any change before switching. [2]

The quarterly option means fewer scheduled dosing days, not one oversized injection. [2] Consider upcoming travel, the space needed for delivery and storage, and whether your pharmacy can supply the correct package. A schedule that looks convenient on paper is useful only if you can follow it consistently.

A healthcare professional should provide injection training. Ajovy is supplied in a prefilled autoinjector or syringe. [1] Ask which device will be dispensed, then use its complete instructions. If you need help because of vision, hand movement, or anxiety, arrange it before the first dose. Ask the pharmacist about storage and disposal rather than adapting instructions from another injectable medicine.

Ajovy also has a pediatric indication

The current U.S. label includes prevention of episodic migraine in children ages 6 through 17 who weigh at least 45 kg, about 99 pounds. That is different from the adult indication. [6] This article focuses on adults, and TeleHeadache serves people 18 and older. Pediatric approval does not establish eligibility for this adult service or permit applying an adult quarterly schedule to a child.

What should you track during treatment?

In a randomized trial of adults with chronic migraine, both studied fremanezumab regimens reduced qualifying headache days more than placebo over 12 weeks. The trial did not directly establish that one schedule was more effective than the other. [5] Your result may differ from a trial average, and fewer dosing days should not be interpreted as stronger prevention.

Agree with the clinician on a review date and what would count as worthwhile benefit. A brief calendar can capture headache days, migraine symptoms, attack-medicine days, injection dates, and activities missed. Add side effects as they occur. A record kept on ordinary days is more informative than a summary written while you are having a particularly difficult attack.

For example, you might report fewer missed shifts even though headaches still occur. Or you may have fewer headache days but still struggle with long attacks. Describe that difference. Include any delayed dose or unrelated medicine change so the clinician can judge whether the trial was consistent enough to interpret.

Which Ajovy warnings matter?

Injection-site reactions are the most common labeled side effects. The current safety information also identifies serious risks that deserve a clear action plan. [3]

• Allergy: Seek emergency help for trouble breathing or swelling of the face, mouth, tongue, or throat. [7] Reactions may appear hours to a month after an injection. Do not use Ajovy after a serious allergy to it or its ingredients. [1]
• Constipation with serious complications: This warning applies to Ajovy. Report severe constipation promptly, especially with persistent or severe abdominal pain, vomiting, bloating, or abdominal swelling. [7] Reported complications with CGRP antibodies have included hospital care and surgery. [3]
• Hypertension: Ajovy may cause new high blood pressure or worsen existing hypertension. Tell the clinician about increased readings and ask how blood pressure will be monitored. [3]
• Raynaud's phenomenon: Report new or worsening cold, painful, numb, or discolored fingers or toes. [7] The labeling advises stopping Ajovy and contacting a healthcare professional if these symptoms develop. [3]

Discuss existing constipation, circulation symptoms, and blood pressure before starting. Bring every prescription, over-the-counter medicine, and supplement. Also discuss pregnancy plans or breastfeeding; the patient information does not establish safety for an unborn baby or whether Ajovy enters breast milk. A pregnancy exposure registry is available. [7]

Frequently asked questions

Can I choose the quarterly option myself?

Discuss your preference with the prescriber. The prescription and pharmacy supply need to match the chosen regimen. Do not independently combine doses, shorten the interval, or switch between schedules to manage breakthrough symptoms.

What happens if I miss a dose?

The label says to administer a missed dose as soon as possible and schedule subsequent doses from that date. [1] Ask the pharmacist or clinician to clarify the new calendar if you are uncertain. Document a supply delay rather than silently restarting the old schedule.

Does a prescription mean insurance will pay?

No. Ask the pharmacy about coverage, authorization, and your expected cost before arranging delivery. Read Why prescriptions sometimes need prior authorization. Keep the denial or request for information so your care team can address the specific issue.

Considering preventive care through TeleHeadache

TeleHeadache can assess eligible adults 18 and older who are physically located in Florida for appropriate nonurgent headache care. A clinician can discuss prevention and prescribe when appropriate after assessing eligibility. Medication and pharmacy costs are separate from the clinical membership, and insurance approval is not guaranteed. Share your headache record, treatment history, and preferred schedule to support that conversation.

Official medication information and further reading

Official Ajovy website · Ajovy on Drugs.com · Drugs.com

Use the current U.S. prescribing information and your own prescription instructions when discussing this medicine with your clinician or pharmacist.

Educational information supports a discussion with your clinician and does not replace individualized medical evaluation. Medication choice and prescribing require clinical review.